Detalles de la búsqueda
1.
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus.
Int J Mol Sci
; 25(6)2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38542146
2.
Improved glycaemic control in patients with type 2 diabetes has a beneficial impact on NAFLD, independent of change in BMI or glucose lowering agent.
Nutr Metab Cardiovasc Dis
; 33(3): 640-648, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36710114
3.
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease.
Int J Mol Sci
; 24(8)2023 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37108675
4.
Promoting weight loss and psychological well-being in patients with obesity: A sequential combination of behavioural lifestyle intervention and well-being therapy.
Clin Psychol Psychother
; 30(2): 422-435, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36436883
5.
Liraglutide 3.0 mg and mental health: can psychiatric symptoms be associated to adherence to therapy? Insights from a clinical audit.
Eat Weight Disord
; 28(1): 99, 2023 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38015342
6.
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease.
Eat Weight Disord
; 28(1): 100, 2023 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38055131
7.
A psycho-educational intervention for the prevention of foot lesions in people with diabetes: Report of a clinical audit.
Nutr Metab Cardiovasc Dis
; 32(9): 2264-2272, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35843798
8.
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis.
Liver Int
; 41(4): 731-742, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33497019
9.
Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy.
Nutr Metab Cardiovasc Dis
; 30(6): 1014-1022, 2020 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32423665
10.
Maternal PKU: Defining phenylalanine tolerance and its variation during pregnancy, according to genetic background.
Nutr Metab Cardiovasc Dis
; 30(6): 977-983, 2020 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32409273
11.
Dysfunctional eating in type 2 diabetes mellitus: A multicenter Italian study of socio-demographic and clinical associations.
Nutr Metab Cardiovasc Dis
; 29(9): 983-990, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31353206
12.
The treatment of diabetes in advanced liver disease: change of a paradigm.
Ann Hepatol
; 28(1): 100772, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36261110
13.
Expected benefits and motivation to weight loss in relation to treatment outcomes in group-based cognitive-behavior therapy of obesity.
Eat Weight Disord
; 23(2): 205-214, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29368291
14.
Non-alcoholic fatty liver disease: Not time for an obituary just yet!
J Hepatol
; 74(4): 972-974, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33340575
15.
NASH: A glance at the landscape of pharmacological treatment.
Ann Hepatol
; 15(5): 673-81, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27493105
16.
The Effect of Liraglutide on ß-Blockade for Preventing Variceal Bleeding: A Case Series.
Ann Intern Med
; 173(5): 404-405, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32449885
17.
Adipose tissue-associated cancer risk: Is it the fat around the liver, or the fat inside the liver?
J Hepatol
; 71(6): 1073-1075, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31586595
18.
Rehabilitation in obesity with comorbidities: a consensus document from experts of the Italian Society of Physical and Rehabilitation Medicine (SIMFER), the Italian Society of Obesity (SIO) and the Italian Society of Eating Disorders (SISDCA).
Eat Weight Disord
; 19(3): 383-6, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24890911
19.
Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting.
Aliment Pharmacol Ther
; 59(2): 249-259, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843741
20.
Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity.
Acta Diabetol
; 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38684539